HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCWB is trading 9.9% down today after terminating its Wugen license deal to regain molecule rights
HCWB is trading approximately 9.9% down at $2.36 after announcing the termination of its exclusive worldwide license agreement with Wugen. • By ending the...
HCW Biologics Terminates Wugen Agreement, Regains Full Rights to Two Immunotherapeutics
HCW Biologics Inc. announced it has terminated its exclusive worldwide license agreement with Wugen Inc., regaining full ex vivo rights to its...
🔴 HCWB is trading 12.1% down today on profit-taking after a massive multi-session rally
HCWB is trading 12.1% down today at $2.54 as the stock enters a consolidation phase following a dramatic surge from $0.34 to the mid-$2 range. • The recent...
🟢 HCWB is trading 5% up today, extending recent rally driven by Q1 results and financing
HCWB is trading 5% up at $2.72 in pre-market, continuing a major rally that began in mid-May. • The surge appears driven by strong Q1 2026 financial results...
🟢 HCWB is trading 27% up today after $4M private placement and preclinical data
HCWB is trading at $3.26 (+26.53%) today after announcing a $4.0 million private placement and releasing positive preclinical data for its T-cell engager...
🟢 HCWB is trading 55% up today after a $4M private placement and promising preclinical data
HCWB is trading 55% up at $4.01 in pre-market trading, extending a significant two-day rally following key corporate updates. • The company secured a $4.0...
HCW Biologics Announces ~$4.0 Million Private Placement with Accredited Investors
HCW Biologics Inc. entered into a Securities Purchase Agreement with accredited investors to raise approximately $4.0 million in gross proceeds. The private...
HCW Biologics Raises $4 Million for Clinical Trials Following Triple-Digit Rally
HCW Biologics Inc. (NASDAQ: HCWB) priced an at-the-market private placement of 2,846,975 units to healthcare investors. The company raised approximately $4.0...
🔴 HCWB is trading 17.7% down today as momentum fades from its recent licensing deal rally amid broader market weakness
HCWB is trading 17.7% down at $2.00 as the stock pulls back from its prior session peak of $2.43 following a licensing-driven rally. • The decline follows a...
I need to research the latest news about HCW Biologics (HCWB) to get specific facts and figures for this briefing.
HCWB Soars 500% in a Week on CAR-T Buzz and a One-Time Deal — But Can a Company Running on Fumes Sustain It? Shares of HCW Biologics slipped 13.2% in...
🔴 HCWB is trading 9.5% down today on profit-taking after massive multi-day rally
HCWB is trading 9.5% down at $2.20 as momentum cools following an extreme multi-day rally. • Shares previously surged 129.25% on May 20 and over 260% on May...
🔴 HCWB is trading 8% down today on profit-taking after a 129% regular-session surge
HCWB is trading about 8% down in after-hours at $2.18 as traders lock in profits following a massive 129.25% regular-session surge to $2.43. • The reversal...
🔴 HCWB is trading 8% down today on profit-taking after massive 129% surge
HCWB is trading at $2.23, down 8% in after-hours action as the stock eases off a 129.25% surge recorded during the prior regular session. • The pullback...
🔴 HCWB is trading 6% down today amid speculative volatility following recent momentum-driven surges
HCWB is trading about 6% down in after-hours at $2.29 as the stock eases back from a 129.25% surge amid extreme speculative volatility. • There are no fresh...
🟢 HCWB is trading 20.8% up today as it rebounds from recent volatility
HCWB is trading at $1.28 (+20.8%), rebounding sharply as speculative trading continues following extreme price swings in recent sessions. • The stock is...
🔴 HCWB is trading 5.7% down today as it eases back after recent extreme volatility
HCWB is trading 5.7% down today at $1.00 in pre-market as it continues to digest recent speculative gains and extreme price volatility. • The stock is pulling...
HCW Biologics Inc Q1 2026 Earnings Preview: What Analysts Expect on May 21, 2026
As HCW Biologics prepares for its Q1 2026 earnings call, analysts are modeling a consensus net loss of $0.44 per share on zero core revenue, with the stock...
HCW Biologics' One-Time Licensing Windfall Fades Fast — Can a Company With $1.2M in Cash Survive What Comes Next?
Shares of HCW Biologics slid 16% to $1.12 on May 19, after a blistering rally that had tripled the stock from $0.34 to $1.34 in a single session last week. The...
🔴 HCWB is trading 16% down today as profit-taking follows a one-time licensing-driven spike
HCWB is trading at $1.12 (16.0% down) as traders lock in profits following a recent surge triggered by a one-time $6.5 million licensing payment. • The $6.5...
🟢 HCWB is trading 6.6% up today on rare Q1 swing to profitability via $6.5M licensing deal
HCWB is trading 6.6% up today at $1.30 after swinging to a rare Q1 profitability driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. • The...